CML is a myeloproliferative disorder that, in common with APL, is characterised by a specific chromosomal translocation, in this case t(9;22), which gives rise to the tyrosine kinase BCR-ABL. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.